BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹97.4 Cr | -0.1% | -13.4% | -73.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹249,145.0 Cr | -2.4% | -12.8% | -11.3% | Stock Analytics | |
| REDINGTON | ₹16,988.0 Cr | -6.7% | -16% | -2.8% | Stock Analytics | |
| HONASA CONSUMER | ₹9,414.6 Cr | 8.6% | -4.1% | 33.2% | Stock Analytics | |
| MMTC | ₹8,964.0 Cr | 13.8% | -5.9% | 22.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,910.7 Cr | -1.2% | -22.9% | 32.1% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -0.1% |
-13.4% |
-73.8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses